Vascular Grafts Market by Product and Geography - Forecast and Analysis 2022-2026

Published: Apr 2022 Pages: 149 SKU: IRTNTR72428

The vascular grafts market share is expected to increase by USD 1.55 billion by 2026, and the market's growth momentum will progress at a CAGR of 7.22%. This vascular grafts market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches.

The vascular grafts market report extensively covers market segmentations, including product (endovascular grafts, bypass grafts, hemodialysis grafts, and peripheral grafts) and geography (North America, Europe, Asia, and Rest of World (ROW))

The vascular grafts market vendors compiled and studied in this report are Abbott Laboratories, Artivion Inc., Aruga Technologies, B. Braun Melsungen AG, Becton Dickinson and Co., Bentley InnoMed GmbH, BIOTRONIK SE and Co. KG, BIOVIC Sdn Bhd, Cardinal Health Inc., Cook Group Inc., Endologix Inc., Getinge AB, Heart Medical Europe BV, InnAVasc Medical Inc., Japan Lifeline Co. Ltd., LeMaitre Vascular Inc., Lombard Medical Ltd., Medtronic Plc, MicroPort Scientific Corp., Terumo Corp., Vascular Graft Solutions Ltd., and W. L. Gore and Associates Inc. among others.

What will the Vascular Grafts Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Vascular Grafts Market Size for the Forecast Period and Other Important Statistics

 

Vascular Grafts Market: Key Drivers, Trends, and Challenges

The ubiquity of CVDs and other vascular disorders is notably driving the vascular grafts market growth, although factors such as risks and complications associated with vascular grafting may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the vascular grafts industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Vascular Grafts Market Driver

One of the key factors driving the global vascular grafts industry growth is the ubiquity of CVDs and other vascular disorders. For instance, in 2020, the CDC estimated that the primary cause of 15,000 deaths every year was due to Aortic aneurysms, and the same cause has been the reason behind the 9,863 deaths in the United States in 2014. In addition, in September 2021, CDC estimated nearly 116 million US adults have hypertension. Out of all affected individuals, nearly 47% of the people have control. In 2021, alone 37.3 million Americans have diabetes. Thus, the growing demand for vascular grafts due to the increased usage of CVDs, diabetes, and other chronic conditions will drive the market growth during the forecast period.

Key Vascular Grafts Market Trend

Technological improvements is one of the key vascular grafts market trends that is expected to impact the industry positively in the forecast period. Vendors are coming up with technologically advanced products to cater to the market demand.

  • For instance, in 2017, Vascular Flow Technologies reached an agreement with Biovic, a Malaysian biomedical business, to develop the innovative Avatar Spiral Laminar Flow (SLF) vascular graft.
  • The Omniflow II Biosynthetic Vascular graft for Peripheral Revascularization and AV Access introduced by LeMaitre Vascular is designed to provide superior strength and durability to resist the formation of aneurysm for years after the implantation.

These advancements across the product segment of vascular grafts will further support the market growth.

Key Vascular Grafts Market Challenge

One of the key challenges to the global vascular grafts industry growth is the risks and complications associated with vascular grafting and the use of off-level devices. The usage of off-label devices can sometimes give positive results. Thus, some countries are in favor of using off-label devices such as vascular grafts. For instance, Germany supports the usage of off-label vascular grafts for clinical settings. Since 2016, as per FDA, it has been observed that 15% of the off-label vascular stent grafts are used to perform complex AAA repairs. According to a comparative study named Clinical outcomes of Endurant II stent-graft for infrarenal aortic aneurysm repair: comparison of on-label versus off-label use, the off-label use of Medtronic's Endurant II was truly justified in patients, where the usage of conventional open surgery is not recommended. This may limit the market growth in the coming years.

This vascular grafts market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global vascular grafts market as part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the vascular grafts market during the forecast period.

Who are the Major Vascular Grafts Market Vendors?

The report analyzes the market's competitive landscape and offers information on several market vendors, including:

 

  • Abbott Laboratories
  • Artivion Inc.
  • Aruga Technologies
  • B. Braun Melsungen AG
  • Becton Dickinson and Co.
  • Bentley InnoMed GmbH
  • BIOTRONIK SE and Co. KG
  • BIOVIC Sdn Bhd
  • Cardinal Health Inc.
  • Cook Group Inc.
  • Endologix Inc.
  • Getinge AB
  • Heart Medical Europe BV
  • InnAVasc Medical Inc.
  • Japan Lifeline Co. Ltd.
  • LeMaitre Vascular Inc.
  • Lombard Medical Ltd.
  • Medtronic Plc
  • MicroPort Scientific Corp.
  • Terumo Corp.
  • Vascular Graft Solutions Ltd.
  • W. L. Gore and Associates Inc.

 

This statistical study of the vascular grafts market encompasses successful business strategies deployed by the key vendors. The vascular grafts market is fragmented and the vendors are deploying the following growth strategies to compete in the market:

  • M&A activities
  • Investment in research and development (R&D) 

Product Insights and News

  • Abbott Laboratories - The company offers vascular grafts such as GRAFTMASTER RX Coronary Stent Graft System. 
  • Abbott Laboratories - In December 2021, the company appointed Robert B. Ford as Chairman of the Board. 

To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The vascular grafts market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Vascular Grafts Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the vascular grafts market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Vascular Grafts Market?

For more insights on the market share of various regions Request for a FREE sample now!

42% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for vascular grafts in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW.

The advances and improvements in the healthcare infrastructure, high prevalence of cardiovascular disorders and AAA, and increased healthcare expenditure by private entities will facilitate the vascular grafts market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The sudden outbreak of COVID-19 in countries across North America led to the imposition of lockdowns to prevent the spread of the infection in 2020. The increasing number of COVID-19 cases across North America has delayed many discretionary surgical procedures, including cardiac surgeries in healthcare facilities in the region, to avoid the risk of transmission of COVID-19 infection. However, the outbreak has prompted vendors to develop new business strategies such as online promotion activities and training for doctors to meet the high demand for vascular grafts. This will help the regional market to grow during the forecast period.

What are the Revenue-generating Product Segments in the Vascular Grafts Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The vascular grafts market share growth by the endovascular grafts segment will be significant during the forecast period. The growth is attributed to the outspread applications of endovascular grafts in treating AAA and the growing preference for MI EVAR.

This report provides an accurate prediction of the contribution of all the segments to the growth of the vascular grafts market size and actionable market insights on the post-COVID-19 impact on each segment.

 

Vascular Grafts Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 7.22%

Market growth 2022-2026

$1.55 billion

Market structure

Fragmented

YoY growth (%)

6.61

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 42%

Key consumer countries

US, Canada, Germany, UK, and China

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Abbott Laboratories, Artivion Inc., Aruga Technologies, B. Braun Melsungen AG, Becton Dickinson and Co., Bentley InnoMed GmbH, BIOTRONIK SE and Co. KG, BIOVIC Sdn Bhd, Cardinal Health Inc., Cook Group Inc., Endologix Inc., Getinge AB, Heart Medical Europe BV, InnAVasc Medical Inc., Japan Lifeline Co. Ltd., LeMaitre Vascular Inc., Lombard Medical Ltd., Medtronic Plc, MicroPort Scientific Corp., Terumo Corp., Vascular Graft Solutions Ltd., and W. L. Gore and Associates Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Vascular Grafts Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive vascular grafts market growth during the next five years
  • Precise estimation of the vascular grafts market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the vascular grafts industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of vascular grafts market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Product

    • 5.1 Market segments
      • Exhibit 24: Chart on Product - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
    • 5.2 Comparison by Product
      • Exhibit 26: Chart on Comparison by Product
      • Exhibit 27: Data Table on Comparison by Product
    • 5.3 Endovascular grafts - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Endovascular grafts - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Endovascular grafts - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Endovascular grafts - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Endovascular grafts - Year-over-year growth 2021-2026 (%)
    • 5.4 Bypass grafts - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Bypass grafts - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Bypass grafts - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Bypass grafts - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Bypass grafts - Year-over-year growth 2021-2026 (%)
    • 5.5 Hemodialysis grafts - Market size and forecast 2021-2026
      • Exhibit 36: Chart on Hemodialysis grafts - Market size and forecast 2021-2026 ($ million)
      • Exhibit 37: Data Table on Hemodialysis grafts - Market size and forecast 2021-2026 ($ million)
      • Exhibit 38: Chart on Hemodialysis grafts - Year-over-year growth 2021-2026 (%)
      • Exhibit 39: Data Table on Hemodialysis grafts - Year-over-year growth 2021-2026 (%)
    • 5.6 Peripheral grafts - Market size and forecast 2021-2026
      • Exhibit 40: Chart on Peripheral grafts - Market size and forecast 2021-2026 ($ million)
      • Exhibit 41: Data Table on Peripheral grafts - Market size and forecast 2021-2026 ($ million)
      • Exhibit 42: Chart on Peripheral grafts - Year-over-year growth 2021-2026 (%)
      • Exhibit 43: Data Table on Peripheral grafts - Year-over-year growth 2021-2026 (%)
    • 5.7 Market opportunity by Product
      • Exhibit 44: Market opportunity by Product ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 46: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 47: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 48: Chart on Geographic comparison
      • Exhibit 49: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 Germany - Market size and forecast 2021-2026
      • Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.9 UK - Market size and forecast 2021-2026
      • Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 7.10 China - Market size and forecast 2021-2026
      • Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.11 Canada - Market size and forecast 2021-2026
      • Exhibit 82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 84: Chart on Canada - Year-over-year growth 2021-2026 (%)
      • Exhibit 85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 86: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 87: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 89: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 90: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 91: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 92: Matrix on vendor position and classification
            • 10.3 Abbott Laboratories
              • Exhibit 93: Abbott Laboratories - Overview
              • Exhibit 94: Abbott Laboratories - Business segments
              • Exhibit 95: Abbott Laboratories - Key news
              • Exhibit 96: Abbott Laboratories - Key offerings
              • Exhibit 97: Abbott Laboratories - Segment focus
            • 10.4 Artivion Inc.
              • Exhibit 98: Artivion Inc. - Overview
              • Exhibit 99: Artivion Inc. - Business segments
              • Exhibit 100: Artivion Inc. - Key offerings
              • Exhibit 101: Artivion Inc. - Segment focus
            • 10.5 B. Braun Melsungen AG
              • Exhibit 102: B. Braun Melsungen AG - Overview
              • Exhibit 103: B. Braun Melsungen AG - Business segments
              • Exhibit 104: B. Braun Melsungen AG - Key news
              • Exhibit 105: B. Braun Melsungen AG - Key offerings
              • Exhibit 106: B. Braun Melsungen AG - Segment focus
            • 10.6 Becton Dickinson and Co.
              • Exhibit 107: Becton Dickinson and Co. - Overview
              • Exhibit 108: Becton Dickinson and Co. - Business segments
              • Exhibit 109: Becton Dickinson and Co. - Key news
              • Exhibit 110: Becton Dickinson and Co. - Key offerings
              • Exhibit 111: Becton Dickinson and Co. - Segment focus
            • 10.7 Cardinal Health Inc.
              • Exhibit 112: Cardinal Health Inc. - Overview
              • Exhibit 113: Cardinal Health Inc. - Business segments
              • Exhibit 114: Cardinal Health Inc. - Key news
              • Exhibit 115: Cardinal Health Inc. - Key offerings
              • Exhibit 116: Cardinal Health Inc. - Segment focus
            • 10.8 Cook Group Inc.
              • Exhibit 117: Cook Group Inc. - Overview
              • Exhibit 118: Cook Group Inc. - Product / Service
              • Exhibit 119: Cook Group Inc. - Key offerings
            • 10.9 LeMaitre Vascular Inc.
              • Exhibit 120: LeMaitre Vascular Inc. - Overview
              • Exhibit 121: LeMaitre Vascular Inc. - Product / Service
              • Exhibit 122: LeMaitre Vascular Inc. - Key offerings
            • 10.10 Medtronic Plc
              • Exhibit 123: Medtronic Plc - Overview
              • Exhibit 124: Medtronic Plc - Business segments
              • Exhibit 125: Medtronic Plc - Key news
              • Exhibit 126: Medtronic Plc - Key offerings
              • Exhibit 127: Medtronic Plc - Segment focus
            • 10.11 Terumo Corp.
              • Exhibit 128: Terumo Corp. - Overview
              • Exhibit 129: Terumo Corp. - Business segments
              • Exhibit 130: Terumo Corp. - Key news
              • Exhibit 131: Terumo Corp. - Key offerings
              • Exhibit 132: Terumo Corp. - Segment focus
            • 10.12 W. L. Gore and Associates Inc.
              • Exhibit 133: W. L. Gore and Associates Inc. - Overview
              • Exhibit 134: W. L. Gore and Associates Inc. - Product / Service
              • Exhibit 135: W. L. Gore and Associates Inc. - Key offerings

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 136: Inclusions checklist
                • Exhibit 137: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 138: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 139: Research methodology
                • Exhibit 140: Validation techniques employed for market sizing
                • Exhibit 141: Information sources
              • 11.5 List of abbreviations
                • Exhibit 142: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              vascular grafts market

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis